“Rapid expansion” of its consumer health-focused Branded Products division through acquisitions is a core focus for Stada Arzneimittel AG in 2019 as its private-equity owners look to ramp up sales and earnings at the unit.
Stada Seeking OTC Acquisitions After Strong 2018 As Private-Equity Owners Begin To Flex Muscles
Germany's Stada is on the look out for consumer health acquisitions globally that can help it reach its ambition to grow faster than the market in 2019. The firm's new private-equity owners are backing CEO Peter Goldschmidt's plan to take the Branded Products division to the next level.
More from Strategy
• By
Jump in cough & cold sales at the end of the year helps Recordati post higher OTC revenues for 2024.
• By
Italy's Alfasigma has expanded its operation in Germany with the creation of a new Consumer Healthcare unit. Led by Rüdiger Hoppe, the business is rolling out OTC medical devices and dietary supplements in the gastrointestinal category.
• By
Round up of the latest appointments: PAGB names vice presidents; Activ'Inside gets first US head; EMA elects management board chair.
• By
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
More from Business
• By
HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.
• By
A round-up of the latest consumer health industry appointments: GSCF elects chair; Kenvue hires Northern Europe head; Barentz names chief commercial officer.
• By
Galenica outpaced the growth of the OTC market at home, while recording a double-digit gain abroad, to drive up its consumer health product sales in 2024.